Armata Pharmaceuticals (ARMP) Total Debt (2018 - 2026)
Armata Pharmaceuticals (ARMP) reported Total Debt of $88.0 million for Q1 2026, up 217.67% on a YoY basis from $27.7 million in Q1 2025, and down 14.64% sequentially from $103.1 million in Q4 2025.
Armata Pharmaceuticals (ARMP) Total Debt (2018 - 2026) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 7 years of Total Debt data on file, last reported at $88.0 million in Q1 2026.
- For the quarter ending Q1 2026, Total Debt rose 217.67% year-over-year to $88.0 million; the trailing twelve-month figure through Mar 2026 stood at $88.0 million (up 217.67% YoY), and the FY2025 full-year result was $103.1 million, up 357.26% from the prior year.
- Total Debt eased to $88.0 million in Q1 2026, from $103.1 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $107.0 million in Q1 2024 to a low of $22.3 million in Q3 2023.
- A 4-year average of $52.8 million and a median of $41.4 million in 2024 frame the typical range for Total Debt.
- Peak annual rise in Total Debt reached 357.26% in 2025, while the deepest fall reached 74.12% in 2025.
- Tracing ARMP's Total Debt over 4 years: stood at $23.7 million in 2023, then dropped by 4.79% to $22.5 million in 2024, then surged by 357.26% to $103.1 million in 2025, then decreased by 14.64% to $88.0 million in 2026.
- Business Quant data shows ARMP's Total Debt at $88.0 million in Q1 2026, $103.1 million in Q4 2025, and $63.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - | 87.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.98 Mn |
| Dec 31, 2025 | 103.06 Mn |
| Sep 30, 2025 | 63.33 Mn |
| Jun 30, 2025 | 33.45 Mn |
| Mar 31, 2025 | 27.69 Mn |
| Dec 31, 2024 | 22.54 Mn |
| Sep 30, 2024 | 41.36 Mn |
| Jun 30, 2024 | 48.26 Mn |
| Mar 31, 2024 | 107.03 Mn |
| Dec 31, 2023 | 23.67 Mn |
| Sep 30, 2023 | 22.28 Mn |
| Dec 31, 2020 | 1.94 Mn |
| Sep 30, 2020 | 1.77 Mn |
| Jun 30, 2020 | 1.62 Mn |
| Mar 31, 2020 | 1.48 Mn |
| Dec 31, 2019 | 970,000.00 |
| Sep 30, 2019 | 885,000.00 |
| Jun 30, 2019 | 769,000.00 |
| Dec 31, 2018 | 970,000.00 |